Bladder training: Bladder training has 4 components, educating the patient about anatomy, fluid intake control, pelvic floor muscle contractions and increasing the interval between visits to the bathroom
Transcutaneous tibial nerve stimulation: A combined electrotherapy device capable of applying transcutaneous electrical nerve stimulation will be used. Each session will take 30 minutes. Patient will visit the hospital twice a week for 6 weeks. An electrical current of 0-50 amperes with a frequency of 20 herz, and a duration of 200 micro seconds will be applied using 50x50 mm surface electordes. The aim is to create a tingling sensation without causing any pain on the tibial nerve, at the ankle level.
Study summary
This study was designed to assess the efficacy of trans cutaneous tibial nerve stimulation on symptoms of overactive bladder in women with idiopathic overactive bladder
Eligibility
Sex
FEMALE
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria:
* Overactive Bladder Questionnaire Validation Study questionnaire 8 scores higher than 11.
* Post voiding residue levels less than 100 ml.
* Women aged between 18-70
Exclusion Criteria:
* Prior history of pelvic surgery
* Pelvic organ prolapsus of grade 2 or more.
* Current urinary tract infection
Primary outcome measure(s)
Urination frequency — 1 day The frequency of urination will be recorded by using a bladder diary. Urination frequency will be questioned before and after the study period.
Severity of overactive bladder symptoms. Overactive Bladder Questionnaire Validation Study questionnaire — 1 day This questionnaire assesses the severity of overactive bladder symptoms in 8 items. Each item is scored from 0 to 5. Higher scores denote worse symptom severity. Maximum score is 40. A score over 11 denotes presence of overactive bladder symptoms. Questionnaire will be answered before and after the treatment period.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.